Progress in second-line antibody therapies for advanced esophageal squamous cell carcinoma
{{output}}
Introduction: The prognosis of advanced esophageal squamous cell carcinoma (ESCC) is poor. Although cytotoxic drugs have been widely used in advanced ESCC, several antibody agents have recently been reported to be effective. ... ...
